Xinfeng Capsule Inhibits Pyroptosis and Ameliorates Myocardial Injury in Rats with Adjuvant Arthritis via the GAS5/miR-21/TLR4 Axis
DOI: https://doi.org/10.2147/dddt.s456783
IF: 4.3188
2024-06-20
Drug Design Development and Therapy
Abstract:Wanlan Fu, 1 Yunxiang Cao, 2 Jian Liu, 2 Chuanbing Huang, 2 Kaiyan Shu, 1 Nanfei Zhu 1 1 First Clinical Medical College, Anhui University of Chinese Medicine, Hefei, Anhui, 230012, People's Republic of China; 2 Department of Rheumatology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, People's Republic of China Correspondence: Yunxiang Cao, Department of Rheumatology, First Affiliated Hospital of Anhui University of Chinese Medicine, 117 Meishan Road, Shushan District, Hefei, Anhui, 230031, People's Republic of China, Tel +86-13514984395 ; +0551-62838591, Email Purpose: This study probed the mechanism of action of Xinfeng Capsule (XFC) in myocardial injury in rats with adjuvant arthritis (AA) via the growth arrest-specific transcript 5 (GAS5)/microRNA-21 (miR-21)/Toll-like receptor 4 (TLR4) axis. Methods: Rats were injected with Freund's complete adjuvant to establish a rat model of AA. Then, some modeled rats were given normal saline or drugs only, and some modeled rats were injected with adeno-associated viruses or necrosulfonamide (NSA; a pyroptosis inhibitor) before drug administration. Toe swelling and arthritis index (AI) were calculated. Pathological and morphological changes in synovial and myocardial tissues were analyzed with hematoxylin-eosin staining, and pyroptotic vesicles and the ultrastructural changes of myocardial tissues were observed with transmission electron microscopy. The serum levels of interleukin (IL)-1β, IL-18, IL-6, and tumor necrosis factor (TNF)-α were detected, and lactate dehydrogenase (LDH) release was measured in myocardial tissues, accompanied by the examination of GAS5, miR-21, TLR4, nuclear factor-kB (NF-κB) p65, nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), Caspase-1, and Gasdermin D (GSDMD) expression in myocardial tissues. Results: After AA modeling, rats presented with significantly increased toe swelling and AI scores, synovial and myocardial tissue damage, elevated pyroptotic vesicles, and markedly enhanced serum levels of IL-1β, IL-18, IL-6, and TNF-α, accompanied by significantly diminished GAS5 expression, substantially augmented miR-21, TLR4, NF-κB p65, NLRP3, Caspase-1, and GSDMD expression, greatly increased LDH release in myocardial tissues. XFC treatment significantly declined toe swelling, AI scores, synovial and myocardial tissue damage, and the serum levels of IL-1β, IL-18, IL-6, and TNF-α in AA rats. Additionally, XFC treatment markedly elevated GAS5 expression and substantially lowered LDH release and miR-21, TLR4, NF-κB p65, NLRP3, Caspase-1, and GSDMD expression in myocardial tissues of AA rats. Moreover, the above effects of XFC in AA rats were further promoted by GAS5 overexpression or NSA treatment. Conclusion: XFC alleviated myocardial injury in AA rats by regulating the GAS5/miR-21/TLR4 axis and inhibiting pyroptosis and pro-inflammatory cytokine secretion. Keywords: adjuvant arthritis, myocardial injury, GAS5/miR-21/TLR4 axis, pyroptosis, Xinfeng Capsule Rheumatoid arthritis (RA), a chronic systemic inflammatory disease, can lead to joint deformity and dysfunction. 1 RA patients often present with a variety of extra-articular manifestations and comorbidities, including cardiovascular, respiratory, digestive, and cutaneous disorders since this disease involves multiple extra-articular organs, particularly the heart. 2 Moreover, RA has been demonstrated as an independent risk factor for cardiovascular disease (CVD). 3 Reportedly, the mortality rate of CVD is 1.5 times higher in RA patients than in the general population. 4 In some special cases of RA, extra-articular symptoms may precede the onset of articular symptoms, thereby affecting the regression and prognosis of RA. 2,5 Considering the unclear pathogenesis of RA, it is essential for the management of cardiac damage secondary to RA to elucidate the pathogenic mechanisms. Pyroptosis is a novel type of inflammatory programmed cell death that is mediated by Caspase and gasdermin (GSDM) families. 6 It has been reported that pyroptosis is involved in the progression of RA. 7 Pyroptosis-related biological alterations, such as inflammasome formation, activation of Caspases and GSDM proteins, and release of numerous pro-inflammatory cytokines (interleukin [IL]-1β, IL-18, IL-6, and tumor necrosis factor [TNF]-α), are pivotal triggers of RA. 8 Similarly, pyroptosis has an important role in the pathogenesis of CVD which is associated with cardiomyocytes, vascular endothelial cells, and macrophages. 9 Myocardial pyroptosis is widely involved in myocardial injury of various cause -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal